3231 - 3240 of 4301 Drugs
Pepaxto (melphalan flufenamide for injection for iv use)
Pepaxto (melphalan flufenamide) is an alkylating drug indicated in combination with dexamethasone, to treat adult patients with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy and whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and one CD38-directed monoclonal antibody.
Namenda (memantine hcl)
Namenda (memantine hydrochloride) is an orally active NMDA receptor antagonist used to treat moderate to severe Alzheimer's type dementia.
Namenda XR (memantine hydrochloride extended release capsules)
Namenda XR (memantine hydrochloride) Extended Release is an NMDA receptor antagonist used to treat moderate to severe dementia of the Alzheimer's type.
Namzaric (memantine hydrochloride extended-release and donepezil hydrochloride capsules)
Namzaric (memantine hydrochloride extended-release and donepezil hydrochloride) is a combination of an orally active NMDA receptor antagonist, and a reversible inhibitor of the enzyme acetylcholinesterase, used to treat moderate to severe dementia of the Alzheimer's type in patients stabilized on memantine hydrochloride and donepezil hydrochloride.
Menactra (polysaccharide diphtheria toxoid conjugate vaccine)
Menactra (polysaccharide diphtheria toxoid conjugate vaccine) is an immunization used to prevent infection caused by meningococcal bacteria. Menactra vaccine contains four of the most common types of meningococcal bacteria that cause the body to produce its own protection (antibodies) against the bacteria.
Menveo (meningococcal (groups a, c, y and w-135) oligosaccharide diphtheria crm197)
Menveo [Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine] is an immunization used to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135.
Trumenba (meningococcal group b vaccine)
Trumenba (Meningococcal Group B Vaccine) Suspension for intramuscular injection is a vaccine indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B. Trumenba is approved for use in individuals 10 through 25 years of age.